The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria
Open accessAbstract
Large neutral amino acids (LNAAs), including phenylalanine (Phe), compete for transport across the blood-brain barrier (BBB) via the L-type amino acid carrier. Accordingly, elevated plasma Phe impairs brain uptake of other LNAAs in patients with phenylketonuria (PKU). Direct effects of elevated brain Phe and depleted LNAAs are probably major causes for disturbed brain development and function in PKU. Competition for the carrier might conversely be put to use to lower Phe influx when the plasma concentrations of all other LNAAs are increased. This hypothesis was tested by measuring brain Phe in patients with PKU by quantitative 1H magnetic resonance spectroscopy during an oral Phe challenge with and without additional supplementation with all other LNAAs. Baseline plasma Phe was approximately 1,000 micromol/l and brain Phe was approximately 250 micromol/l in both series. Without LNAA supplementation, brain Phe increased to approximately 400 micromol/l after the oral Phe load. Electroencephalogram (EEG) spectral analysis revealed acutely disturbed brain activity. With concurrent LNAA supplementation, Phe influx was completely blocked and there was no slowing of EEG activity. These results are relevant for further characterization of the LNAA carrier and of the pathophysiology underlying brain dysfunction in PKU and for treatment of patients with PKU, as brain function might be improved by continued LNAA supplementation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kinetics of Neutral Amino Acid Transport Across the Blood‐Brain Barrier
Smith, Q. R., Momma, S., Aoyagi, M., & Rapoport, S. I. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb01039.x · Cited by 454
Guldberg, P., Rey, F., Zschocke, J., Romano, V., François, B., Michiels, L., Ullrich, K., Hoffmann, G. F., Burgard, P., Schmidt, H., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301920 · Cited by 353
Kinetic analysis of blood-brain barrier transport of amino acids
Pardridge, W. M., & Oldendorf, W. H. (1975) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(75)90347-8 · Cited by 314
Blood-Brain Barrier Carrier-Mediated Transport and Brain Metabolism of Amino Acids
Pardridge, W. M. (1998) · Neurochemical Research · doi:10.1023/a:1022482604276 · Cited by 281
Neuropsychology of Early-treated Phenylketonuria: Specific Executive Function Deficits
Welsh, M. C., Pennington, B. F., Ozonoff, S. J., Rouse, B. M., & McCabe, E. R. B. (1990) · Child Development · doi:10.1111/j.1467-8624.1990.tb03560.x · Cited by 277
Neutral amino acid transport at the human blood-brain barrier.
Hargreaves, K. M., & Pardridge, W. M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77645-5 · Cited by 199
Krause, W., Halminski, M., McDonald, L., et al. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111695 · Cited by 194
Neuropsychology of Early-Treated Phenylketonuria: Specific Executive Function Deficits
Welsh, M. C., Pennington, B. F., Ozonoff, S., Rouse, B., & McCabe, E. R. B. (1990) · Child Development · doi:10.2307/1130832 · Cited by 181
Versatile frequency domain fitting using time domain models and prior knowledge
Slotboom, J., Boesch, C., & Kreis, R. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910390607 · Cited by 167
Self-citationONE DRUG (PHENYTOIN) IN TREATMENT OF EPILEPSY
Gunn, J., Reynolds, E. H., Chadwick, D., & Galbraith, A. W. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92881-6 · Cited by 167
Cited by
Blau, N., van Spronsen, F. J., & Levy, H. L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60961-0 · Cited by 1,086
The complete European guidelines on phenylketonuria: diagnosis and treatment
van Wegberg, A. M. J., MacDonald, A., Ahring, K., Bélanger-Quintana, A., Blau, N., Bosch, A. M., Burlina, A., Campistol, J., Feillet, F., Giżewska, M., et al. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0685-2 · Cited by 830
Phenylalanine hydroxylase deficiency
Mitchell, J. J., Trakadis, Y. J., & Scriver, C. R. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182141b48 · Cited by 536
Branched-Chain Amino Acids and Brain Function
Fernstrom, J. D. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.6.1539s · Cited by 514
van Spronsen, F. J., Blau, N., Harding, C., Burlina, A., Longo, N., & Bosch, A. M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00267-0 · Cited by 497
ThePAH gene, phenylketonuria, and a paradigm shift
Scriver, C. R. (2007) · Human Mutation · doi:10.1002/humu.20526 · Cited by 336
Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
del Amo, E. M., Urtti, A., & Yliperttula, M. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.06.015 · Cited by 319
Mechanisms of Disease: The Blood-Brain Barrier
Neuwelt, E. A. (2004) · Neurosurgery · doi:10.1227/01.neu.0000097715.11966.8e · Cited by 314
Panel, N. I. O. H. C. D. (2001) · Pediatrics · doi:10.1542/peds.108.4.972 · Cited by 274
Phenylketonuria Scientific Review Conference: State of the science and future research needs
Camp, K. M., Parisi, M. A., Acosta, P. B., Berry, G. T., Bilder, D. A., Blau, N., Bodamer, O. A., Brosco, J. P., Brown, C. S., Burlina, A. B., et al. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.02.013 · Cited by 261
Wiersema, J. R., van der Meere, J. J., & Roeyers, H. (2005) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-0110-1 · Cited by 37
Metabolism of carnitine in phenylacetic acid-treated rats and in patients with phenylketonuria
Fischer, G. M., Nemeti, B., Farkas, V., Debreceni, B., Laszlo, A., Schaffer, Z., Somogyi, C., & Sandor, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00023-5 · Cited by 20
“PKU is the most serious form of the defective degradations because the accumulating phenylalanine [15] causes mental retardation [15,16].”
Background
Metadata
- Authors
- Pietz, J., Kreis, R., Rupp, A., Mayatepek, E., Rating, D., Boesch, C., & Bremer, H. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-04-15
- Volume
- 103
- Issue
- 8
- Pages
- 1169-1178
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2052438797
- Cited by
- 300
- References
- 33
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.